JDD April 2024 Issue Highlights
Introducing the April 2024 Editorial Highlights from the Journal of Drugs in Dermatology! This month's issue is packed with groundbreaking research and insights into dermatologic treatments and practices. From original articles exploring innovative therapies for conditions like photoaging and acne vulgaris to case reports shedding light on rare dermatologic phenomena, this issue offers a comprehen …
Introducing the April 2024 Editorial Highlights from the Journal of Drugs in Dermatology! This month's issue is packed with groundbreaking research and insights into dermatologic treatments and practices. From original articles exploring innovative therapies for conditions like photoaging and acne vulgaris to case reports shedding light on rare dermatologic phenomena, this issue offers a comprehen … 
The latest buzz word in hidradenitis suppurativa treatment is combination. Without a single, consistently and widely effective therapy, it’s important to build your own regimen by combining treatments, says Dr. Steven Daveluy, associate professor of dermatology and residency program director at Wayne State University School of Medicine. Next Steps in Derm, in partnership with ODAC Dermatology, A … 
ABSTRACT
Dyschromia is a concern for many patients, especially persons of color. Postinflammatory hypopigmentation and depigmentation can affect all skin types; however, it is more apparent in those with darker skin. Some members of the dermatology community may not comprehensively understand the mechanisms of these reactions and the extent of the psychosocial effect they have on persons of color … 
March into groundbreaking dermatological insights with the latest issue of the Journal of Drugs in Dermatology! Explore the prescribing habits of oral minoxidil for androgenetic alopecia, delve into a comprehensive review of botulinum toxin uses, and discover the effectiveness of microneedling for acne scars. Plus, unravel the uncertainties surrounding exosome therapy in androgenetic alopecia. Fro … 